Clonazepam for Treatment of Sleep Disturbances Associated with Combat-Related Posttraumatic Stress Disorder
- 1 September 2004
- journal article
- clinical trial
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 38 (9) , 1395-1399
Abstract
BACKGROUND: Clonazepam is widely used for the treatment of posttraumatic stress disorder (PTSD)—related sleep disturbances despite very limited published data supporting its use for this indication. OBJECTIVE: We conducted a pilot-controlled trial to provide more data on this clinical practice and lay the foundation for more definitive studies. METHODS: The study was designed as a randomized, single-blind (ie, patient only), placebo-controlled, crossover clinical trial involving administration of clonazepam 1 mg at bedtime for one week followed by 2 mg at bedtime for one week. The following week served as a washout period before the alternate treatment was begun. Patients completed sleep diaries each morning upon awakening throughout the study. Parameters included quantity of sleep, quality of sleep, frequency and intensity of difficulty falling or staying asleep, and frequency and intensity of recurrent distressing dreams. RESULTS: Six patients with combat-related PTSD participated in the study. There were no statistically significant differences between clonazepam and placebo for any measure, although clonazepam therapy resulted in mild to moderate numeric improvements in difficulty falling or staying asleep. Adverse effects of clonazepam were generally mild and essentially indiscernible from those attributed to placebo. Only one patient elected to receive further treatment with clonazepam at the conclusion of the trial. CONCLUSIONS: Clonazepam therapy was largely ineffective in improving sleep disturbances, particularly nightmares, associated with combat-related PTSD. The small sample size was a significant limitation of this study, but the prospective design and single-blind, placebo-control parameters were strengths. Further studies are needed to further define the role of this widespread clinical practice.Keywords
This publication has 10 references indexed in Scilit:
- Chronic Sleep Disruption and the Reexperiencing Cluster of Posttraumatic Stress Disorder Symptoms Are Improved by OlanzapineThe Primary Care Companion For CNS Disorders, 2003
- Reduction of Nightmares and Other PTSD Symptoms in Combat Veterans by Prazosin: A Placebo-Controlled StudyAmerican Journal of Psychiatry, 2003
- Sleep in Posttraumatic Stress DisorderAnnals of Clinical Psychiatry, 2002
- Pharmacotherapy for post-traumatic stress disorder: a comprehensive reviewExpert Opinion on Pharmacotherapy, 2001
- Benzodiazepine Use in Posttraumatic Stress Disorder among Veterans with Substance AbuseJournal of Nervous & Mental Disease, 2000
- Treatment for Posttraumatic Stress DisorderAnnals of Pharmacotherapy, 2000
- Nefazodone in post-traumatic stress disorder: results from six open-label trialsInternational Clinical Psychopharmacology, 1999
- Sleep events among veterans with combat-related posttraumatic stress disorderAmerican Journal of Psychiatry, 1995
- The development of a clinician‐administered PTSD scaleJournal of Traumatic Stress, 1995
- Comments on Posttraumatic Stress DisorderAmerican Journal of Psychiatry, 1989